Eric Anschutz

Unknown · Independent · San Francisco, United States

Email

Verified, deliverable email

Experienced angel with biotech focus. Selective deal flow supported by quantitative evaluation system. Proven, exit-driven results over 20+ years. Bike lover.

Stages: Seed, Pre-seed, Series A
Sectors: AI, Health tech
Cheque size: €9k–€230k
Location: San Francisco, United States
Freshness: Verified today
Fund size: $2.1M

Notable investments

Prism AIPre-Seed · $1 · 2024
R2DIOSeed · 2023
AverySeed · $1 · 2022
Attivare TherapeuticsSeed · $1 · 2021
HDT BioSeed Round · $6M · 2021
Primordial GeneticsSeed Round · $1 · 2021
SMBXSeed Round · $2.5M · 2020
MycoWorksSeed · $1 · 2018

Frequently co-invests with

Arvind GuptaMayfield FundDovi FrancesGroup 11George GodulaLife BiosciencesJohn LegendJordan FliegelTechstarsKesha CashImpact America FundMaximilian WinterHarmonix FundPeter BordesTrajectory VenturesPeter LivingstonUnpopular VenturesPo BronsonSOSVSeth BermanSusa VenturesTony FadellFuture Shape

Related lists

AI investors Health tech investors Seed AI in United States Pre-seed AI in United States Series A AI in United States

Similar investors

Ross SternManaging Director, Summit Partners

Richard SocherInvestor, AIX Ventures

Raymond LiaoVice President, Samsung NEXT Ventures

Phin UphamManaging Partner, Haymaker Ventures

Rick KushelGeneral Partner, FINTOP Capital

Rohan PuranikPartner, WestWave Capital

Every contact is a verified, deliverable email. How Mintround verifies contacts.

Are you Eric Anschutz? Request removal of this listing.